Next Article in Journal
Unseen Weapons: Bacterial Extracellular Vesicles and the Spread of Antibiotic Resistance in Aquatic Environments
Previous Article in Journal
Oxidative Stress-Mediated Repression of Virulence Gene Transcription and Biofilm Formation as Antibacterial Action of Cinnamomum burmannii Essential Oil on Staphylococcus aureus
Previous Article in Special Issue
Specific Activation of T Cells by an ACE2-Based CAR-Like Receptor upon Recognition of SARS-CoV-2 Spike Protein
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 25
Issue 5
10.3390/ijms25053079
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders

by
Panagiotis Mallis
1,2,*,
Efstathios Michalopoulos
1 and
Catherine Stavropoulos-Giokas
1
1
Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens (BRFAA), 115 27 Athens, Greece
2
Immunology Department & National Tissue Typing Center, General Hospital of Athens “Gennimatas”, 154 Mesogeion Ave., 115 27 Athens, Greece
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(5), 3079; https://doi.org/10.3390/ijms25053079
Submission received: 28 February 2024 / Accepted: 2 March 2024 / Published: 6 March 2024
(This article belongs to the Special Issue Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders)
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Advanced Therapy Medicinal Products (ATMPs) comprise a heterogenous class of innovative medicinal products, which further require extensive preclinical and clinical assessments before their broader use in the general population [...]

Share and Cite

MDPI and ACS Style

Mallis, P.; Michalopoulos, E.; Stavropoulos-Giokas, C. Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders. Int. J. Mol. Sci. 2024, 25, 3079. https://doi.org/10.3390/ijms25053079

AMA Style

Mallis P, Michalopoulos E, Stavropoulos-Giokas C. Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders. International Journal of Molecular Sciences. 2024; 25(5):3079. https://doi.org/10.3390/ijms25053079

Chicago/Turabian Style

Mallis, Panagiotis, Efstathios Michalopoulos, and Catherine Stavropoulos-Giokas. 2024. "Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders" International Journal of Molecular Sciences 25, no. 5: 3079. https://doi.org/10.3390/ijms25053079

APA Style

Mallis, P., Michalopoulos, E., & Stavropoulos-Giokas, C. (2024). Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders. International Journal of Molecular Sciences, 25(5), 3079. https://doi.org/10.3390/ijms25053079

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop